Non-Hispanic Black and Hispanic/Latino children were also significantly less likely to receive brain MRI scans compared with ...
A device long used by adults to manage migraines was now available for children as young as eight years old, offering new ...
The manufacturer of AV-101, an investigational, oral nonopioid, NMDA-targeting therapy to treat neuropathic pain, announced that it has received a U.S. patent for the treatment. AV-101 (4-Cl-KYN) is ...
The Kentucky Children’s Health Pediatric Advanced Care Team offers some families the chance to transport their child home using life-sustaining tech.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback